PF-04745637

CAS No. 1917294-46-2

PF-04745637( —— )

Catalog No. M26002 CAS No. 1917294-46-2

PF-04745637 is a potent and selective TRPA1 antagonist with an IC50 of 17 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 222 In Stock
10MG 311 In Stock
25MG 525 In Stock
50MG 750 In Stock
100MG 1035 In Stock
500MG 2061 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    PF-04745637
  • Note
    Research use only, not for human use.
  • Brief Description
    PF-04745637 is a potent and selective TRPA1 antagonist with an IC50 of 17 nM.
  • Description
    PF-04745637 is a potent and selective TRPA1 antagonist with an IC50 of 17 nM.(In Vivo):PF-04745637 (topically applied; 50 mg/mL and 100 mg/mL) significantly reduces cinnamaldehyde-mediated flare in rat skin.
  • In Vitro
    ——
  • In Vivo
    Topically applied PF-04745637 (Compound 8; 50 mg/mL and 100 mg/mL) significantly reduces cinnamaldehyde-mediated flare in rat skin.
  • Synonyms
    ——
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    TRP/TRPV Channel
  • Recptor
    Immunology/Inflammation related
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1917294-46-2
  • Formula Weight
    509.01
  • Molecular Formula
    C27H32ClF3N2O2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 125 mg/mL (245.58 mM)
  • SMILES
    OC1(CCN(CC1)C(CNC(=O)C1(CCCC1)c1ccc(Cl)cc1)Cc1ccccc1)C(F)(F)F
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Constituents of Compositae plants III. Anti-tumor promoting effects and cytotoxic activity against human cancer cell lines of triterpene diols and triols from edible chrysanthemum flowers.Cancer Lett., 2002, 177(1):7-12.
molnova catalog
related products
  • JNJ-38893777

    JNJ-38893777 is a potent and selective transient receptor potential vanilloid 1 (TRPV1) channel antagonist for treatment of ociceptive and neuropathic pain.

  • TRPC6-PAM-C20

    TRPC6-PAM-C20 is a selective TRPC6 positive allosteric modulator. TRPC6-PAM-C20 induces transient increase in intracellular Ca2+ in HEK cells expressing TRPC6 with an EC50 of 2.37 μM. TRPC6-PAM-C20 enhances OAG-induced platelet aggregation.

  • NGD-8243

    NGD-8243 is a TRPV1 inhibitor and can be used in studies for prevention and treatment of cardiac hypertrophy.